Journey Medical (DERM) Long-Term Deferred Tax (2020 - 2021)
Journey Medical's (DERM) quarterly Long-Term Deferred Tax came in at $8.4 million in Q3 2021, up 475.03% on a QoQ basis from $1.5 million in Q4 2020.
Journey Medical (DERM) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
Journey Medical (DERM) has 2 years of Long-Term Deferred Tax data on file, last reported at $8.4 million in Q3 2021.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $8.4 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $8.4 million (changed N/A YoY) and the FY2020 annual result came in at $1.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax advanced to $8.4 million in Q3 2021, from $1.5 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $8.4 million in Q3 2021 to a low of $1.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Journey Medical | 208.13 Mn | 182.48 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 8.36 Mn |
| Dec 31, 2020 | 1.45 Mn |